Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDNA CareDx	$13.53	$13.83	$10.96 ▼ $32.97	$720.16M	2.28	1.43 million shs	859,641 shs
FTRE Fortrea	$10.10 -1.3%	$7.40	$3.97 ▼ $25.28	$928.88M	1.91	1.86 million shs	1.48 million shs
LFMD LifeMD	$5.80 -1.5%	$8.41	$3.99 ▼ $15.84	$275.02M	1.56	1.25 million shs	1.50 million shs
PNTG The Pennant Group	$25.58 -0.5%	$24.34	$21.18 ▼ $37.13	$888.59M	1.31	353,162 shs	417,190 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDNA CareDx	0.00%	-2.10%	+11.54%	-27.22%	-52.58%
FTRE Fortrea	-1.27%	-13.16%	+28.83%	+70.90%	-50.80%
LFMD LifeMD	-1.53%	-4.29%	-15.82%	-53.45%	+9.85%
PNTG The Pennant Group	-0.51%	+5.31%	-1.92%	-7.55%	-23.91%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDNA CareDx	$13.53	$13.83	$10.96 ▼ $32.97	$720.16M	2.28	1.43 million shs	859,641 shs
FTRE Fortrea	$10.10 -1.3%	$7.40	$3.97 ▼ $25.28	$928.88M	1.91	1.86 million shs	1.48 million shs
LFMD LifeMD	$5.80 -1.5%	$8.41	$3.99 ▼ $15.84	$275.02M	1.56	1.25 million shs	1.50 million shs
PNTG The Pennant Group	$25.58 -0.5%	$24.34	$21.18 ▼ $37.13	$888.59M	1.31	353,162 shs	417,190 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDNA CareDx	0.00%	-2.10%	+11.54%	-27.22%	-52.58%
FTRE Fortrea	-1.27%	-13.16%	+28.83%	+70.90%	-50.80%
LFMD LifeMD	-1.53%	-4.29%	-15.82%	-53.45%	+9.85%
PNTG The Pennant Group	-0.51%	+5.31%	-1.92%	-7.55%	-23.91%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CDNA CareDx	2.57	Moderate Buy	$25.50	88.47% Upside
FTRE Fortrea	2.17	Hold	$11.50	13.86% Upside
LFMD LifeMD	2.88	Moderate Buy	$13.17	127.01% Upside
PNTG The Pennant Group	2.60	Moderate Buy	$34.40	34.48% Upside

Current Analyst Ratings Breakdown

Latest LFMD, FTRE, PNTG, and CDNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/12/2025	CDNA CareDx	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$22.00
9/9/2025	FTRE Fortrea	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$7.00 ➝ $9.50
9/5/2025	LFMD LifeMD	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
9/4/2025	PNTG The Pennant Group	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$40.00
9/3/2025	FTRE Fortrea	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$9.00 ➝ $14.00
8/26/2025	CDNA CareDx	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Market Perform
8/14/2025	PNTG The Pennant Group	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Equal Weight	$31.00 ➝ $29.00
8/8/2025	CDNA CareDx	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Equal Weight	$19.00 ➝ $14.00
8/8/2025	FTRE Fortrea	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	In-Line	$5.00 ➝ $7.00
8/7/2025	FTRE Fortrea	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Underweight	$5.00 ➝ $6.00
8/7/2025	LFMD LifeMD	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$14.00 ➝ $13.00

(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CDNA CareDx	$333.79M	2.16	$1.36 per share	9.95	$7.06 per share	1.92
FTRE Fortrea	$2.73B	0.34	$1.55 per share	6.51	$15.19 per share	0.66
LFMD LifeMD	$245.56M	1.12	N/A	N/A	($0.09) per share	-64.44
PNTG The Pennant Group	$798.92M	1.11	$0.92 per share	27.89	$9.08 per share	2.82

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CDNA CareDx	$52.55M	$1.02	13.26	N/A	N/A	17.97%	18.03%	12.88%	11/3/2025 (Estimated)
FTRE Fortrea	-$328.50M	-$11.38	N/A	7.89	N/A	-37.57%	5.25%	1.72%	11/14/2025 (Estimated)
LFMD LifeMD	-$18.88M	-$0.21	N/A	48.33	N/A	-2.41%	N/A	-8.11%	11/6/2025 (Estimated)
PNTG The Pennant Group	$22.56M	$0.78	32.79	29.07	2.12	3.36%	9.85%	4.04%	11/5/2025 (Estimated)

Latest LFMD, FTRE, PNTG, and CDNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/6/2025	Q2 2025	CDNA CareDx	$0.12	-$0.16	-$0.28	-$0.16	$90.72 million	$90.51 million
8/6/2025	Q2 2025	FTRE Fortrea	$0.06	$0.19	+$0.13	-$4.14	$631.61 million	$710.30 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CDNA CareDx	N/A	N/A	N/A	N/A	N/A
FTRE Fortrea	N/A	N/A	N/A	N/A	N/A
LFMD LifeMD	N/A	N/A	N/A	N/A	N/A
PNTG The Pennant Group	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CDNA CareDx	N/A	3.30	3.00
FTRE Fortrea	1.87	1.02	1.02
LFMD LifeMD	9.21	0.77	0.72
PNTG The Pennant Group	0.11	1.21	1.21

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CDNA CareDx	N/A
FTRE Fortrea	N/A
LFMD LifeMD	35.52%
PNTG The Pennant Group	85.88%

Insider Ownership

Company	Insider Ownership
CDNA CareDx	4.40%
FTRE Fortrea	0.38%
LFMD LifeMD	18.40%
PNTG The Pennant Group	5.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CDNA CareDx	740	53.23 million	50.89 million	Optionable
FTRE Fortrea	15,500	90.80 million	90.46 million	Optionable
LFMD LifeMD	230	47.42 million	38.69 million	Optionable
PNTG The Pennant Group	7,000	34.56 million	32.70 million	Optionable

LFMD, FTRE, PNTG, and CDNA Headlines

Recent News About These Companies

Pennant Group to Participate in the 2025 Jefferies Healthcare Services Conference

September 11 at 2:13 PM | globenewswire.com

Cubist Systematic Strategies LLC Raises Holdings in The Pennant Group, Inc. $PNTG

September 9, 2025 | marketbeat.com

American Century Companies Inc. Takes $519,000 Position in The Pennant Group, Inc. $PNTG

September 8, 2025 | marketbeat.com

The Pennant Group (NASDAQ:PNTG) Downgraded by Wall Street Zen to Hold

September 8, 2025 | marketbeat.com

The Pennant Group, Inc. $PNTG Shares Sold by Ancora Advisors LLC

September 7, 2025 | marketbeat.com

Graham Capital Management L.P. Has $806,000 Holdings in The Pennant Group, Inc. $PNTG

September 7, 2025 | marketbeat.com

The Pennant Group (NASDAQ:PNTG) Stock Rating Lowered by Wall Street Zen

September 7, 2025 | americanbankingnews.com

Stephens Reiterates "Overweight" Rating for The Pennant Group (NASDAQ:PNTG)

September 6, 2025 | marketbeat.com

The Pennant Group, Inc. $PNTG Shares Purchased by PDT Partners LLC

September 6, 2025 | marketbeat.com

The Pennant Group, Inc. (NASDAQ:PNTG) Receives $33.40 Consensus Target Price from Analysts

September 6, 2025 | americanbankingnews.com

A Glimpse Into The Expert Outlook On Pennant Gr Through 4 Analysts

September 4, 2025 | benzinga.com

12,576 Shares in The Pennant Group, Inc. $PNTG Acquired by Magnetar Financial LLC

September 4, 2025 | marketbeat.com

The Pennant Group, Inc. (NASDAQ:PNTG) Given Consensus Rating of "Moderate Buy" by Brokerages

September 4, 2025 | marketbeat.com

Pennant acquires home health agency, outpatient therapy operation in Wyoming

September 4, 2025 | msn.com

Investing in Pennant Group (NASDAQ:PNTG) three years ago would have delivered you a 60% gain

September 4, 2025 | finance.yahoo.com

The Pennant Group, Inc. Expands Service Area with Acquisition of Healing Hearts Home Health and Outpatient Therapy in Wyoming

September 3, 2025 | quiverquant.comQ

Pennant Announces Home Health Acquisition in Wyoming

September 3, 2025 | globenewswire.com

1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

September 3, 2025 | finance.yahoo.com

8 Knots Management LLC Has $75.80 Million Position in The Pennant Group, Inc. $PNTG

September 3, 2025 | marketbeat.com

Paradigm Capital Management Inc. NY Acquires 16,000 Shares of The Pennant Group, Inc. $PNTG

September 2, 2025 | marketbeat.com

The Pennant Group (PNTG) is an Incredible Growth Stock: 3 Reasons Why

September 1, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFMD, FTRE, PNTG, and CDNA Company Descriptions

CareDx NASDAQ:CDNA

$13.53 0.00 (0.00%)

Closing price 09/12/2025 04:00 PM Eastern

Extended Trading

$13.26 -0.27 (-2.03%)

As of 09/12/2025 05:59 PM Eastern

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Fortrea NASDAQ:FTRE

$10.10 -0.13 (-1.27%)

Closing price 09/12/2025 04:00 PM Eastern

Extended Trading

$10.22 +0.13 (+1.24%)

As of 09/12/2025 07:54 PM Eastern

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

LifeMD NASDAQ:LFMD

$5.80 -0.09 (-1.53%)

Closing price 09/12/2025 04:00 PM Eastern

Extended Trading

$5.84 +0.04 (+0.78%)

As of 09/12/2025 07:34 PM Eastern

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

The Pennant Group NASDAQ:PNTG

$25.58 -0.13 (-0.51%)

Closing price 09/12/2025 04:00 PM Eastern

Extended Trading

$25.58 0.00 (-0.02%)

As of 09/12/2025 04:57 PM Eastern

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFMD, FTRE, PNTG, and CDNA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFMD, FTRE, PNTG, and CDNA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFMD, FTRE, PNTG, and CDNA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFMD, FTRE, PNTG, and CDNA Company Descriptions

CareDx NASDAQ:CDNA

Fortrea NASDAQ:FTRE

LifeMD NASDAQ:LFMD

The Pennant Group NASDAQ:PNTG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFMD, FTRE, PNTG, and CDNA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFMD, FTRE, PNTG, and CDNA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFMD, FTRE, PNTG, and CDNA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFMD, FTRE, PNTG, and CDNA Company Descriptions

CareDx NASDAQ:CDNA

Fortrea NASDAQ:FTRE

LifeMD NASDAQ:LFMD

The Pennant Group NASDAQ:PNTG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools